Jeffrey E. Russel

Array ( [id] => 8363674 [patent_doc_number] => 08252740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Thermally-targeted delivery of medicaments including doxorubicin' [patent_app_type] => utility [patent_app_number] => 12/162283 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 18671 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12162283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237152 [patent_doc_number] => 20070129309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/654881 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11624 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129309.pdf [firstpage_image] =>[orig_patent_app_number] => 11654881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220255 [patent_doc_number] => 20070161566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Method of treating multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/651212 [patent_app_country] => US [patent_app_date] => 2007-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3874 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161566.pdf [firstpage_image] =>[orig_patent_app_number] => 11651212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636378 [patent_doc_number] => 20100035822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'PROLINE-RICH PEPTIDES, PHARMACEUTICAL COMPOSITION, USE OF ONE OR MORE PEPTIDES AND METHOD OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 11/813346 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13262 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035822.pdf [firstpage_image] =>[orig_patent_app_number] => 11813346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 859880 [patent_doc_number] => 07371411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells' [patent_app_type] => utility [patent_app_number] => 11/646128 [patent_app_country] => US [patent_app_date] => 2006-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 47 [patent_no_of_words] => 30365 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371411.pdf [firstpage_image] =>[orig_patent_app_number] => 11646128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070172 [patent_doc_number] => 20070191274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Active hedgehog protein conjugate' [patent_app_type] => utility [patent_app_number] => 11/645014 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10572 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191274.pdf [firstpage_image] =>[orig_patent_app_number] => 11645014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502722 [patent_doc_number] => 20090163410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Novel Peptides and the Biological Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/086243 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5923 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163410.pdf [firstpage_image] =>[orig_patent_app_number] => 12086243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875812 [patent_doc_number] => 08470778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'VIP fragments and methods of use' [patent_app_type] => utility [patent_app_number] => 12/096768 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10881 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12096768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 190933 [patent_doc_number] => 07642244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Neuropeptide-2 receptor (Y-2R) agonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/607230 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16347 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642244.pdf [firstpage_image] =>[orig_patent_app_number] => 11607230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 888168 [patent_doc_number] => 07348308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Glycogen synthase kinase-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/602406 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 21482 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348308.pdf [firstpage_image] =>[orig_patent_app_number] => 11602406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670384 [patent_doc_number] => 20080045444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION' [patent_app_type] => utility [patent_app_number] => 11/560425 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30295 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045444.pdf [firstpage_image] =>[orig_patent_app_number] => 11560425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210412 [patent_doc_number] => 20070248996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Modulators of beta-amyloid peptide aggregation comprising D-amino acids' [patent_app_type] => utility [patent_app_number] => 11/600290 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24934 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248996.pdf [firstpage_image] =>[orig_patent_app_number] => 11600290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363278 [patent_doc_number] => 08252338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Synthetic LDL as targeted drug delivery vehicle' [patent_app_type] => utility [patent_app_number] => 12/084845 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 19061 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12084845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183507 [patent_doc_number] => 20070054861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Therapeutic uses of SMR1 peptides' [patent_app_type] => utility [patent_app_number] => 11/594105 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14810 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054861.pdf [firstpage_image] =>[orig_patent_app_number] => 11594105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8126847 [patent_doc_number] => 20120087969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'Mu-Conotoxin Peptides and Use Thereof as a Local Anesthetic' [patent_app_type] => utility [patent_app_number] => 12/084572 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17115 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20120087969.pdf [firstpage_image] =>[orig_patent_app_number] => 12084572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5096149 [patent_doc_number] => 20070117758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Therapeutic agents and methods of use thereof for the modulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/593998 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17525 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117758.pdf [firstpage_image] =>[orig_patent_app_number] => 11593998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120552 [patent_doc_number] => 20070142267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells' [patent_app_type] => utility [patent_app_number] => 11/591871 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30361 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142267.pdf [firstpage_image] =>[orig_patent_app_number] => 11591871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148180 [patent_doc_number] => 20070048236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Peptide-based conditioners and colorants for hair, skin, and nails' [patent_app_type] => utility [patent_app_number] => 11/592060 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24834 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048236.pdf [firstpage_image] =>[orig_patent_app_number] => 11592060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 167117 [patent_doc_number] => 07666397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Peptide-based conditioners and colorants for hair, skin, and nails' [patent_app_type] => utility [patent_app_number] => 11/592108 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24866 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666397.pdf [firstpage_image] =>[orig_patent_app_number] => 11592108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432313 [patent_doc_number] => 07265086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Glycopeptide carboxy-saccharide derivatives' [patent_app_type] => utility [patent_app_number] => 11/589614 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18833 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265086.pdf [firstpage_image] =>[orig_patent_app_number] => 11589614 [rel_patent_id] =>[rel_patent_doc_number] =>)